Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience

Abstract

Summary:The 5-year overall survival rate of patients with germ cell tumor (GCT) with poor prognosis, according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification, is 48% after standard-dose chemotherapy and surgery, if necessary. Two recent studies have showed that early high-dose chemotherapy (HDCT) with hematopoietic… (More)
DOI: 10.1038/sj.bmt.1704397

Topics

2 Figures and Tables

Cite this paper

@article{Giorgi2004LongtermFO, title={Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience}, author={Ugo De Giorgi and Gianantonio Rosti and Giorgio Papiani and Marina Marangolo}, journal={Bone Marrow Transplantation}, year={2004}, volume={33}, pages={639-643} }